ATE267004T1 - Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen - Google Patents

Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen

Info

Publication number
ATE267004T1
ATE267004T1 AT99954020T AT99954020T ATE267004T1 AT E267004 T1 ATE267004 T1 AT E267004T1 AT 99954020 T AT99954020 T AT 99954020T AT 99954020 T AT99954020 T AT 99954020T AT E267004 T1 ATE267004 T1 AT E267004T1
Authority
AT
Austria
Prior art keywords
progestins
estrogens
administration
delivering drugs
drugs
Prior art date
Application number
AT99954020T
Other languages
English (en)
Inventor
Tommi Markkula
Juha Ala-Sorvari
Harri Jukarainen
Matti Lehtinen
Jarkko Ruohonen
Original Assignee
Schering Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Oy filed Critical Schering Oy
Application granted granted Critical
Publication of ATE267004T1 publication Critical patent/ATE267004T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
AT99954020T 1998-11-12 1999-10-26 Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen ATE267004T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/190,606 US6063395A (en) 1998-11-12 1998-11-12 Drug delivery device especially for the delivery of progestins and estrogens
PCT/FI1999/000887 WO2000028968A1 (en) 1998-11-12 1999-10-26 Drug delivery device, especially for the delivery of progestins and estrogens

Publications (1)

Publication Number Publication Date
ATE267004T1 true ATE267004T1 (de) 2004-06-15

Family

ID=22702031

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99954020T ATE267004T1 (de) 1998-11-12 1999-10-26 Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen

Country Status (30)

Country Link
US (1) US6063395A (de)
EP (1) EP1128811B1 (de)
JP (1) JP2002529493A (de)
KR (1) KR100621426B1 (de)
CN (1) CN1168439C (de)
AR (1) AR021152A1 (de)
AT (1) ATE267004T1 (de)
AU (1) AU760302B2 (de)
BG (1) BG65042B1 (de)
BR (1) BR9915326B1 (de)
CA (1) CA2351068C (de)
CO (1) CO5271704A1 (de)
CZ (1) CZ301609B6 (de)
DE (1) DE69917477T2 (de)
DK (1) DK1128811T3 (de)
EE (1) EE05506B1 (de)
ES (1) ES2221454T3 (de)
HK (1) HK1041814B (de)
HU (1) HU226113B1 (de)
ID (1) ID29190A (de)
IL (2) IL142523A0 (de)
NO (1) NO332168B1 (de)
NZ (1) NZ511216A (de)
PE (1) PE20001041A1 (de)
PL (1) PL194876B1 (de)
PT (1) PT1128811E (de)
RU (1) RU2226387C2 (de)
SK (1) SK286730B6 (de)
WO (1) WO2000028968A1 (de)
ZA (1) ZA200103298B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20060110424A1 (en) * 2000-03-24 2006-05-25 Lyles Mark B Ceramic and metal compositions
EP1272440A2 (de) * 2000-03-24 2003-01-08 Mark B. Lyles Poröse materialien hoher dichte
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
WO2001085132A1 (en) * 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
CA2415349A1 (en) * 2000-08-23 2002-02-28 Akzo Nobel N.V. Testosterone ester formulation for human use
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
KR20040036928A (ko) * 2001-08-31 2004-05-03 쉐링 오와이 약물 전달 시스템
ES2388731T5 (es) * 2002-03-27 2018-01-19 Warner Chilcott (Ireland) Limited Dispositivos de administración de fármacos mediante una matriz intravaginal
JP2006506385A (ja) * 2002-10-22 2006-02-23 ザ バイオメリックス コーポレーション 治療剤を小嚢内デリバリーするための方法およびシステム
EP1438942A1 (de) * 2003-01-17 2004-07-21 Schering Oy Medikamentenabgabevorrichtung für das Mittelohr und Nase
ES2660627T3 (es) 2003-05-15 2018-03-23 Biomerix Corporation Matrices elastoméricas reticuladas, su fabricación y su utilización en dispositivos implantables
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
CA2625264C (en) 2005-10-13 2015-12-15 Synthes (U.S.A.) Drug-impregnated sleeve for a medical implant
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
DK2062569T3 (da) * 2007-11-22 2011-08-29 Bayer Oy Vaginalt afgivelsessystem
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
LT2249757T (lt) 2008-02-04 2017-09-25 Ferring B.V. Vientisi intravaginaliniai žiedai, apimantys progesteroną, ir jų gamybos bei panaudojimo būdai
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
EP2953678B1 (de) 2013-02-06 2020-03-25 Sillender, Mark Transferkatheter für therapeutischen wirkstoff
WO2014121333A1 (en) 2013-02-06 2014-08-14 Sillender Mark Embryo transfer catheter and method
CN105555328B (zh) 2013-06-21 2019-01-11 德普伊新特斯产品公司 膜及制造方法
WO2016180764A1 (en) * 2015-05-13 2016-11-17 Bayer Oy A long acting drug delivery device and its use in contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
JOP20200067A1 (ar) * 2017-09-27 2020-04-27 Bayer Oy طريقة لتعديل اطلاق عامل فعال علاجياً من مادة أساس لدنة
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
US11938140B2 (en) 2022-05-26 2024-03-26 Insigna Inc. Non-surgical prevention of boar taint and aggressive behavior
WO2023230619A1 (en) * 2022-05-26 2023-11-30 Insigna Inc. Prevention of estrus in sow and ruminants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
EP0230654B1 (de) * 1985-12-28 1992-03-18 Sumitomo Pharmaceuticals Company, Limited Arzneimittel mit verzögerter stossweiser Freisetzung
IT8702928A0 (it) * 1987-07-22 1987-07-22 Alga Di Giudici Angelamaria & Friggitrice con cestello rotante secondo un asse orizzontale.
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
JPH07216233A (ja) * 1992-09-21 1995-08-15 Toray Dow Corning Silicone Co Ltd フルオロシリコーンゴム組成物
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens

Also Published As

Publication number Publication date
CO5271704A1 (es) 2003-04-30
ES2221454T3 (es) 2004-12-16
AR021152A1 (es) 2002-06-12
CZ301609B6 (cs) 2010-04-28
EE200100256A (et) 2002-12-16
IL142523A (en) 2006-06-11
PL194876B1 (pl) 2007-07-31
BG105501A (en) 2001-12-29
CA2351068C (en) 2008-09-02
EE05506B1 (et) 2012-02-15
HUP0104037A2 (hu) 2002-04-29
WO2000028968A1 (en) 2000-05-25
DE69917477T2 (de) 2005-06-02
HK1041814A1 (en) 2002-07-26
SK5132001A3 (en) 2001-11-06
BG65042B1 (bg) 2007-01-31
NO20012047D0 (no) 2001-04-26
DK1128811T3 (da) 2004-09-27
PT1128811E (pt) 2004-09-30
US6063395A (en) 2000-05-16
RU2226387C2 (ru) 2004-04-10
EP1128811B1 (de) 2004-05-19
NZ511216A (en) 2002-09-27
PL348113A1 (en) 2002-05-06
JP2002529493A (ja) 2002-09-10
PE20001041A1 (es) 2000-10-14
IL142523A0 (en) 2002-03-10
BR9915326B1 (pt) 2013-10-22
AU760302B2 (en) 2003-05-08
ZA200103298B (en) 2001-10-25
CN1168439C (zh) 2004-09-29
HU226113B1 (en) 2008-04-28
SK286730B6 (sk) 2009-04-06
BR9915326A (pt) 2001-10-09
ID29190A (id) 2001-08-09
HK1041814B (zh) 2005-04-29
KR20010075700A (ko) 2001-08-09
CN1326337A (zh) 2001-12-12
AU1048800A (en) 2000-06-05
NO332168B1 (no) 2012-07-09
DE69917477D1 (de) 2004-06-24
HUP0104037A3 (en) 2003-04-28
NO20012047L (no) 2001-06-28
CA2351068A1 (en) 2000-05-25
CZ20011569A3 (cs) 2001-10-17
EP1128811A1 (de) 2001-09-05
KR100621426B1 (ko) 2006-09-13

Similar Documents

Publication Publication Date Title
ATE267004T1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
DE69909281D1 (de) Vorrichtung zur präsentation und abgabe von mehreren produkten
DE69633294D1 (de) Gerät zur infusion und aspiration in, bzw. aus knochen
BR9703624A (pt) Combinação formulação farmacêutica processo para o tratamento de depressão em um animal uso de mirtazapina uso de um ou mais srri's e embalagem
DE69823869D1 (de) Pharmazeutische hydrogelformulierungen, vorrichtungen zur arzneistoffabgabe und verfahren
DE69927388D1 (de) Gerät zur verabreichung von medikamenten und genen in gewebe
DE69832298D1 (de) Gerät zur kontrollierten abgabe von pharmazeutischen und medizinischen produkten
DE69934773D1 (de) Vorrichtung zur Verabreichung von Medikamenten
IL145983A0 (en) Pharmaceutical composition for dermal use, comprising a corticosteroid and a vitamin d or an analogue thereof
CY2009015I2 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
DE69909801D1 (de) Oral verabreichtes system zur zeitlich und räumlich gesteuerten arzneistoffabgabe
DE59813877D1 (de) Vorrichtung zur Regeneration vom menschlichen und tierischen Knochen, insbesondere im Zahnkieferbereich
DE69720939D1 (de) Vorrichtung zur Abgabe von festen Arzneimitteln
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
ATE293978T1 (de) Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung
ATE453374T1 (de) Verbessertes transdermales verabreichungssystem zur empfängnisverhütung und verfahren
DE60006241D1 (de) Verfahren und vorrichtung zur abgabe von viskosem material
ATE241338T1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
DE29713847U1 (de) Vorrichtung zur Abtrennung magnetischer Materialien aus pharmazeutischen Zubereitungen deren Ausgangs- oder Zwischenprodukten sowie mit Hilfe dieser Vorrichtung hergestellte Mittel
DE50103797D1 (de) Vorrichtung und system zur abgabe bzw. aufnahme/abgabe von flüssigkeitsproben
DE59608609D1 (de) Vorrichtung zur durchführung von manipulationen im menschlichen körper und insbesondere im uterus
DE69719930D1 (de) Verfahren zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung, und Vorrichtung dafür
DE69835035D1 (de) Vorrichtung und verfahren zur verabreichung von flüchtigen wirkstoffen in einem inhalationsströmungsweg
DE60002469D1 (de) Verfahren und vorrichtung zur abgabe von viskosem material
DE69832974D1 (de) Gerät zur intrakardialen verabreichung von medikamenten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1128811

Country of ref document: EP